CompuGroup Medical Strengths, Domain Expertise, and Key Differentiators
CompuGroup Medical (CGM) expanded its healthcare technology portfolio in 2025 through acquisitions of m.Doc GmbH, Medicus Laboratory Information Systems, AP Easy Software Solutions, and perimed, broadening its offerings across patient portals, laboratory systems, pathology, and medical publishing. The company increased its R&D investment to €68 million in Q1 2025, supporting the development of AI-driven and cloud-based products such as CGM ONE, CGM TI-Messenger, CGM CDA, and CGM STELLA. CGM. Its technology strategy emphasizes AI, machine learning, cloud computing, and interoperability standards, while maintaining compliance with data protection and healthcare regulations. CGM’s market presence is strong, particularly in Germany and the US, supported by a broad product portfolio, long-standing domain expertise, and recognition in laboratory and revenue cycle management services.
CompuGroup Medical Recent Developments
In 2024, CGM Germany launched CGM ONE, an AI-powered telephone assistant designed for medical practices to manage multiple incoming calls, gather patient concerns, and automate tasks such as appointment scheduling and prescription renewals without needing integration with existing software. In the pharmacy sector, CGM introduced CGM STELLA, Europe’s first cloud-based pharmacy management platform, along with ASK STELLA, an AI-supported tool for pharmacists. Both products were released in the third quarter of 2024. These solutions aim to improve workflow efficiency through cloud technology. The initiatives reflect CGM’s focus on integrating AI and cloud services into healthcare operations.
CompuGroup Medical Mergers and Acquisitions (M&A) Activities
CompuGroup Medical has significantly expanded its digital healthcare offerings through a series of strategic acquisitions and investments. In 2025, CompuGroup Medical acquired medical publisher Perimed, in 2024, it purchased AmbulApps GmbH and Pridok AS, completed integration of Cerner’s German and Spanish hospital information systems, and received an investment from CVC Capital Partners. In 2023, it acquired a 51 % stake in m.Doc GmbH and in 2022, it bolstered its laboratory and pathology segments by acquiring Medicus Laboratory Information Systems, adding over 1,000 U.S. labs and AP Easy Software Solutions.
CompuGroup Medical Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying CompuGroup Medical applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of CompuGroup Medical and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified CGM APRIMA, eMEDIX, CGM ENROLL, CGM LABDAQ customers.
CompuGroup Medical Overview
Maria Trost 21
Koblenz, x, 56070, Germany
49 261 8000 0
Ownership: - COP.DE : Xetra
Number of Employees: 8299
Functional Markets: Content Management, ERP Services and Operations,
Key Verticals: Healthcare,
CompuGroup Medical Key Enterprise and Cloud Applications
CGM APRIMA, eMEDIX, CGM ENROLL, CGM LABDAQ
CompuGroup Medical Revenues, $M:
| Type/Year | 2023 | 2024 | YoY Growth, % |
|---|---|---|---|
| Total Revenues, $M | Subscribe | Subscribe | Subscribe |
| Enterprise Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
| Cloud Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
CompuGroup Medical Revenue Breakdown By Type, $M:
CompuGroup Medical Enterprise Applications Revenues By Functional Markets, $M:
CompuGroup Medical Enterprise Applications Revenues By Verticals, $M:
CompuGroup Medical Revenues By Region, $M
| Region | % of Total Revenues | 2024 Total Revenues, $M | 2024 Enterprise Applications Revenues, $M | 2024 Cloud Applications Revenues, $M |
|---|---|---|---|---|
| Americas | Subscribe | Subscribe | Subscribe | Subscribe |
| EMEA | Subscribe | Subscribe | Subscribe | Subscribe |
| APAC | Subscribe | Subscribe | Subscribe | Subscribe |
| Total | Subscribe | Subscribe | Subscribe | Subscribe |
CompuGroup Medical Direct vs Indirect sales
| Type | Direct Sales | Indirect Sales | Total |
|---|---|---|---|
| Type % | Subscribe | Subscribe | Subscribe |
| Revenues, $M | Subscribe | Subscribe | Subscribe |
CompuGroup Medical Customers - Breakdown by Geo, Size, Vertical and Product
List of Verified CompuGroup Medical Customers
No. of CompuGroup Medical Customers: x
No. of CompuGroup Medical Enterprise Applications Customers: x
No. of CompuGroup Medical Cloud Customers: x
No. of CompuGroup Medical Cloud Subscribers: x
CompuGroup Medical (CGM) provides a wide range of software solutions used by over 1.6 million healthcare professionals worldwide, including doctors, pharmacists, hospital staff, and laboratory technicians. The company’s recent acquisitions have expanded its offerings to clinics, rehabilitation centers, and medical publishing, supporting integrated digital healthcare across inpatient and outpatient settings. CGM has a strong presence in Europe, particularly Germany, with growing operations in North America and select expansions in Asia and the Middle East. Its products are used in various healthcare segments, including ambulatory information systems, hospital information systems, pharmacy management, and laboratory information systems. CGM’s customer base includes single clinics, major hospital networks, and lab chains, with a gradual shift from on-premise software to cloud-based subscription models.
CompuGroup Medical Market Opportunities, M&A and Geo Expansions
In 2024, CompuGroup Medical (CGM) projects modest organic revenue growth in 2025 compared to 2024, reflecting a cautious outlook amid a slow start to the year. The company’s broad portfolio of software solutions serves healthcare providers across various sectors, supporting expansion into new markets and regions. Increasing demand for digital healthcare records and e-health services presents opportunities for CGM to enhance its offerings and improve healthcare delivery. Recent product launches such as CGM one, CGM TI-Messenger, CGM CDA, and CGM STELLA highlight ongoing investment in innovation. The partnership with CVC Capital Partners may provide additional resources for growth and further geographic expansion.
CompuGroup Medical Risks and Challenges
CompuGroup Medical (CGM) faces several risks as it pursues growth, including the impact of rapid technological and regulatory changes on demand for its products and services. Expanding globally exposes the company to challenges such as cultural differences, diverse regulatory requirements, and geopolitical uncertainties. Increased competition in the e-health sector demands ongoing innovation to retain market position and customer loyalty. The recent partnership with CVC Capital Partners and the planned delisting of shares may bring integration challenges and potential shifts in corporate strategy.
CompuGroup Medical Ecosystem, Partners, Resellers and SI
CompuGroup Medical (CGM) provides a broad range of software solutions that support communication and data management across various healthcare settings, including doctors’ offices, pharmacies, laboratories, hospitals, and social welfare institutions. The company collaborates with several industry partners such as Microsoft, Novovision, and McKesson to enhance innovation and interoperability.
Research Methodology
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:
https://www.appsruntheworld.com/About Ushttps://www.appsruntheworld.com/taxonomy
https://www.appsruntheworld.com/FAQ
